2xN

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

Kvantify is a company based in Copenhagen, Denmark, that specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. Founded in 2022, Kvantify focuses on developing solutions that enhance the efficiency of processes such as drug discovery by utilizing advanced computational drug technology. This technology employs proprietary physics-based methods to improve the quality of compounds tested in laboratories, enabling life sciences companies to expedite small molecule research and achieve actionable results. Through its innovative platform, Kvantify aims to deliver significant value to its clients by solving intricate problems in their respective fields.

QSimulate is a Boston-based company that specializes in developing cloud-based quantitative simulation tools focused on quantum molecular simulations. By leveraging the principles of quantum mechanics, QSimulate aims to address significant industrial-scale challenges primarily within the chemical and pharmaceutical sectors. Its innovative platform automates various workflows, allowing computational scientists to shift their focus from repetitive tasks to more strategic activities, ultimately enhancing productivity. This approach enables clients to accelerate their research and development processes, positioning QSimulate as a key player in advancing scientific inquiry and innovation in these industries.

Kvantify is a company based in Copenhagen, Denmark, that specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. Founded in 2022, Kvantify focuses on developing solutions that enhance the efficiency of processes such as drug discovery by utilizing advanced computational drug technology. This technology employs proprietary physics-based methods to improve the quality of compounds tested in laboratories, enabling life sciences companies to expedite small molecule research and achieve actionable results. Through its innovative platform, Kvantify aims to deliver significant value to its clients by solving intricate problems in their respective fields.

Sparrow Quantum specializes in developing deterministic single-photon sources for advancing light-matter interfaces in quantum technologies. With a focus on high efficiency, purity, indistinguishability, and outcoupling, the company's technology is based on over two decades of research at the Niels Bohr Institute.

QuantrolOx specializes in developing automated machine learning-based control software for quantum technologies, focusing on the tuning, stabilization, and optimization of qubits. By providing robust software solutions, the company aids quantum scientists in achieving stable platforms for experimentation, which enhances the effectiveness of quantum computing applications. This innovative approach allows clients to utilize more cost-effective quantum infrastructure while efficiently implementing standard quantum computing technologies in their operations.

Oxford Ionics specializes in advanced quantum computing systems, focusing on trapped-ion technology. This enables scalable, efficient quantum chips produced via standard semiconductor methods, facilitating advancements in quantum computing and enhancing computational capabilities for complex problems.

Kvantify is a company based in Copenhagen, Denmark, that specializes in quantum computing management software aimed at addressing complex computational challenges across various sectors, including life sciences, financial services, and logistics. Founded in 2022, Kvantify focuses on developing solutions that enhance the efficiency of processes such as drug discovery by utilizing advanced computational drug technology. This technology employs proprietary physics-based methods to improve the quality of compounds tested in laboratories, enabling life sciences companies to expedite small molecule research and achieve actionable results. Through its innovative platform, Kvantify aims to deliver significant value to its clients by solving intricate problems in their respective fields.